- Document
- ST-06
- Section
- Storage fundamentals
- Revised
- Sources checked
- Bands
- −80 °C−20 °C
Freeze/Thaw Cycles: Why Every Thaw Counts
Freezing a peptide solution is not a neutral pause. Ice formation concentrates solutes, shifts pH and creates interfaces. How damage accumulates, and how to design a workflow that avoids it.
Bench card
- Freezing concentrates solutes in the remaining liquid, which can shift pH and drive aggregation.
- Damage accumulates with each cycle, so the goal is zero repeat thaws, not "only a few".
- Aliquot into single-use portions before the first freeze.
- Some phosphate buffers acidify sharply as they freeze. Prefer buffers with small freezing-induced pH shifts where it matters.
- Count every warm-up as a cycle and record it on a log.
Freezing slows chemistry, but the act of freezing and thawing is itself a stress. For peptide solutions, repeated cycles are one of the most common, and most avoidable, causes of lost activity and irreproducible results.
What happens as a solution freezes
As water crystallizes into ice, everything dissolved in it is pushed into a shrinking volume of unfrozen liquid. This freeze-concentration can raise peptide and salt concentrations many-fold. Bhatnagar, Bogner and Pikal describe the separate stresses involved:
- Concentration: crowding promotes aggregation and speeds bimolecular reactions.
- pH shifts: buffer components can crystallize unevenly. Sodium phosphate buffers are a well-documented example, with large pH drops during freezing.
- Ice-liquid interfaces: large interfacial areas can unfold or adsorb molecules.
- Cold denaturation: mainly a concern for folded proteins, less so for short peptides.
Rate matters, but not simply
Cao and colleagues showed that freezing and thawing rates affect protein damage in solution, and that the best combination depends on the system. For a research lab the practical points are simple: freeze aliquots promptly rather than leaving them on the bench, thaw them in one step at a controlled temperature, and do not refreeze.
Why “a few cycles” is the wrong target
Damage from each cycle adds up. One thaw may cause no detectable change; several may cause measurable aggregation or loss of the parent peak on HPLC. Because the threshold differs for every sequence and buffer, the reliable rule is to design for no repeat thaws at all.
Designing a freeze/thaw-free workflow
- Plan aliquot size from the amount one experiment uses.
- Dissolve once and dispense all aliquots in the same session. See Aliquoting.
- Freeze promptly at −20 °C, or −80 °C for longer holds or sensitive sequences.
- Thaw one aliquot at a time, keep it cold, use it and discard the remainder.
- Log withdrawals so an aliquot’s history is known. A printable log is on the Labels & Log Sheets page.
Buffer and additive choices
If a solution must be frozen, the buffer matters. Pikal-Cleland and colleagues showed that sodium phosphate buffers can drop several pH units on freezing, while potassium phosphate shifts much less. For simple research stock solutions, dilute acetic acid or water is often used precisely because there is little buffer to crystallize. Cryoprotectants such as sugars can reduce freezing damage but also change the solution, so add them only when the experiment allows.
LOG-FT
Freeze/thaw and withdrawal log
| # | Date | Time out | Time back | Volume taken | Purpose / experiment ref. | Observations | Initials |
|---|---|---|---|---|---|---|---|
| 1 | |||||||
| 2 | |||||||
| 3 | |||||||
| 4 | |||||||
| 5 | |||||||
| 6 | |||||||
| 7 | |||||||
| 8 |
Count every warm-up above the storage band as one cycle, even if the tube was not opened. Retire the aliquot at the cycle limit your validation supports.
References
- Cao E, Chen Y, Cui Z, Foster PR. Effect of freezing and thawing rates on denaturation of proteins in aqueous solutions. Biotechnol Bioeng. 2003;82(6):684–690. DOI
- Bhatnagar BS, Bogner RH, Pikal MJ. Protein stability during freezing: separation of stresses and mechanisms of protein stabilization. Pharm Dev Technol. 2007;12(5):505–523. DOI
- Pikal-Cleland KA, Rodríguez-Hornedo N, Amidon GL, Carpenter JF. Protein denaturation during freezing and thawing in phosphate buffer systems: monomeric and tetrameric β-galactosidase. Arch Biochem Biophys. 2000;384(2):398–406. DOI
- Wang W. Protein aggregation and its inhibition in biopharmaceutics. Int J Pharm. 2005;289(1–2):1–30. DOI
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544–575. DOI